Press Release – New York, NY – August 26, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented Dominari Securities LLC as the lead underwriter in the recently priced $15 million initial public offering of Curanex Pharmaceuticals Inc. (Nasdaq: CURX), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases.
The Dominari Securities team was led by Kyle Wool and Eric Newman.
Pacific Century Securities LLC and Revere Securities LLC acted as co-underwriters for the offering.
The SRFC team was led by partners Ross Carmel and Shane Wu, with counsel Martryn Mak and associate Xing Yang.
